“He has also abandoned the FCC’s posture as an independent regulator in favor of an openly personal embrace of Trump. Though picked by the president, FCC chairs of both parties for years have charted an independent course, launching investigations and passing rules that affect billions of dollars in corporate investment while being careful to operate at a distance from the White House.
No longer: In April, alongside officials at the Justice Department, Carr donned a golden pin featuring Donald Trump’s face. He’s become a familiar presence at Mar-a-Lago, and has flown with the president on Air Force One.
As he picks those norm-busting fights with the mainstream media, Carr is more quietly delivering on big deregulation promises to business interests. These moves are less headline-grabbing, but possibly more transformational.
Carr recently said he wants the FCC to get into the business of online speech, potentially making the commission a major enforcer against the content moderation decisions of the Big Tech platforms like Meta and Google. And despite his stepped-up scrutiny of some legacy networks and shows, he also wants to scale back government restrictions on the owners of individual radio and TV stations.
His tactics are a window into how even relatively stolid, independent Washington agencies are being transformed under the second Trump administration — expanding their remit, rewarding favored players and lending their weight to Trump’s highly personal fights.”
“Staff reductions and reassignments led by DOGE are slowing the pace of claims processing as field offices lose longtime staff and gain a smaller number of inexperienced replacements. DOGE-driven changes to the agency’s website are causing crashes almost every day, and phone customers complain about dropped calls and long wait times. A DOGE-imposed spending freeze is leading to shortages of basic office supplies, from printer cartridges to the phone headsets staff need to do their jobs.
And on Friday, Social Security leaders told employees that the agency was ending a security check, developed at DOGE’s request, that was meant to root out allegedly fraudulent claims filed over the phone, according to three employees familiar with the situation and an email obtained by The Washington Post. But the measure – which involved placing a three-day hold on all phone claims as other staffers checked into the caller’s background – had only identified a couple of potential fraud cases while causing significant delays in claims processing, two employees said.
Kathleen Romig, a former Social Security official who is now at the left-leaning Center on Budget and Policy Priorities, said there were already safeguards in place to detect fraud through the agency’s phone service. DOGE’s efforts have only delayed claims processing and, like most of the team’s attempts to reshape Social Security, placed serious stress on the agency, she said.
“So much of this is self-inflicted wounds,” Romig said.
This account of turmoil within the Social Security Administration is based on interviews with eight current and former employees, most of whom spoke on the condition of anonymity because they were not authorized to discuss private deliberations. The Post also reviewed more than a dozen pages of internal agency records and communications.”
“President Donald Trump’s administration has thrown the NNSA into chaos, threatening hard-won staffing progress amid a trillion-dollar nuclear weapons upgrade. Desperately needed nuclear experts are wary of joining thanks to chaotic job cuts by Elon Musk’s Department of Government Efficiency, experts say.
The disruption of NNSA’s chronically understaffed safety workforce is “a recipe for disaster,” said Joyce Connery, former head of the Defense Nuclear Facilities Safety Board.”
…
“Nuclear weapons workers don’t grow on trees, nor do the federal experts who oversee them. Many of the jobs require advanced degrees, and new hires often need years of on-the-job training. Security clearance requirements limit the most sensitive jobs to U.S. citizens.”
“Former Vice President Mike Pence said it’s a “bad idea” for President Donald Trump to receive a luxury jet from Qatar, arguing that accepting the gift could be unconstitutional and jeopardize national security.
“There are profound issues – the potential for intelligence gathering, the need to ensure the president of the United States is safe and secure as he travels around the world,” Pence told NBC’s “Meet the Press” in an interview released on May 16.
Accepting the plane “is inconsistent with our security, with our intelligence needs,” he added. “My hope is the president reconsiders it.””
Trump repeatedly acts corruptly, and our institutions are not working properly to stop it.
The Congress should investigate and possibly impeach for such corruption, but the Speaker of the House dismisses it as false claims while saying that what the Biden crime family did was worse, even though those allegations are misleading bullshit.
“Donald Trump doesn’t think Americans deserve stuff. The right number of pencils for a family? Five. The right number of dolls for a little girl? Two, maybe three. His comments in recent interviews bear a striking similarity to those of left-wing Sen. Bernie Sanders (I–Vt.), who in 2015 famously bemoaned that consumers have too many deodorant options.
How did Trump—who campaigned on a promise of reducing inflation—become so eager to have Americans pay more for everyday commodities? While Trump may have made overtures to reducing prices, he’s long supported the kinds of economic interventions most likely to lead to inflation. And if you believe that protectionism is the path to prosperity for everyday Americans, your definition of prosperity starts to change pretty quickly.”
“In 2023, the most recent year for which full data are available, the average U.S. tariff on British goods was 3.3 percent.
That means this “deal” charges American consumers a 10 percent baseline tax on goods that were previously taxed at 3.3 percent. That’s not a win for free trade or lower prices.”
“Thousands of unharvested tomatoes are being plowed over in South Florida in a sign of what is to come under President Donald Trump’s tariffs—or tariff threats—and immigration policies. Reporting by Miami’s local Fox affiliate, WVSN, revealed that farmers are cutting their losses and letting crops go to waste due to increased picking and packing costs.
“You can’t even afford to pick them right now,” Heather Moehling, president of Miami-Dade County Farm Bureau, told WVSN. “Between the cost of labor and the inputs that goes in, it’s more cost-effective for farmers to just plow them right now.””
…
“Even though the tariffs on Mexican imports never took effect for goods compliant with the United States-Mexico-Canada Agreement, including U.S. tomatoes, the threat of tariffs alone was enough to disrupt the U.S. market, DiMare told WVSN.”
…
“While Trump is touting his recent deals with the United Kingdom and China as examples of how his trade policies are working, the Florida tomato industry serves as a real-world reminder that unpredictable policies can have far-reaching and unintended consequences on Americans’ livelihoods. On some level, Trump knows this and has admitted that Americans will have to make do with less, despite being voted in to bring down the cost of living. The president’s attempts at centralized planning will continue to drive prices up, and Americans will be the ones paying the price.”
“If enacted across the board, Trump’s order would mean pharmaceutical companies must sell drugs to Americans at the lowest prices they were offering anybody else in the world.”
…
“Americans do pay significantly more for prescription drugs than people in other developed nations, but the reasons for that are more complicated than Trump suggests.
“There are many good reasons why we should pay more for earlier access to new medications than our trading partners,” wrote Darius Lakdawalla and Dana Goldman of the University of Southern California’s Schaeffer Institute for Public Policy & Government Service. “As the world’s largest market for pharmaceuticals, America finds itself in the unique position of accruing the lion’s share of the benefits from new medicines. We often recoup these additional costs in the form of longer and healthier lives.””
…
“”facing a choice between deep cuts in their U.S. pricing or the loss of weakly profitable overseas markets,” the companies may simply exit foreign markets altogether, “leaving U.S. consumers with the same prices, pharmaceutical manufacturers with lower profits, and future generations with less innovation.””